Yohann Loriot
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Mokbel S, Baciarello G, Lavaud P, Omlin A, Calabrò F, Cathomas R, Aeppli S, Parent P, Giannatempo P, Koster K, Appel N, Gonnet P, Angius G, Tsantoulis P, Arkenau H, Cattrini C, Messina C, Zeghondy J, Morelli C, Loriot Y, Formica V, Patrikidou A. Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors. Cancers (Basel) 2024; 16
11.04.2024Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
11.04.2024Cancers (Basel) 2024; 16
Mokbel Sara, Baciarello Giuilia, Lavaud Pernelle, Omlin Aurelius, Calabrò Fabio, Cathomas Richard, Aeppli Stefanie, Parent Pauline, Giannatempo Patrizia, Koster Kira-Lee, Appel Naara, Gonnet Philippe, Angius Gesuino, Tsantoulis Petros, Arkenau Hendrick-Tobias, Cattrini Carlo, Messina Carlo, Zeghondy Jean, Morelli Cristina, Loriot Yohann, Formica Vincenzo, Patrikidou Anna
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees
Khoo V, N'Dow J, Necchi A, Neuzillet Y, Oddens J, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel M, Pieters B, Plass K, Remzi M, Müller C, Müller A, Kiltie A, Krege S, Ladoire S, Lara P, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir M, Moschini M, Mostafid H, Retz M, Richenberg J, Turkbey B, Lauridsen S, Valdagni R, Der Heijden A, Van Poppel H, Vartolomei M, Veskimäe E, Vilaseca A, Rivera F, Wiegel T, Wiklund P, Williams A, Zigeuner R, Tombal B, Thalmann G, Rink M, Roghmann F, Rosenberg J, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk R, Smits A, Stenzl A, Horwich A, Kamat A, Witjes J, Arends T, Bamias A, Birtle A, Black P, Bochner B, Bolla M, Boormans J, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Agarwal N, Xylinas E, Babjuk M, Bellmunt J, Bruins H, de Reijke T, De Santis M, Gillessen Sommer S, James N, MacLennan S, Palou J, Powles T, Ribal M, Shariat S, Der Kwast T, Chiti A, Choudhury A, Gontero P, Grubmüller B, Hafeez S, Hansel D, Hartmann A, Hayne D, Henry A, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa B, Geavlete B, Gakis G, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig J, Fanti S, Fonteyne V, Frydenberg M, Futterer J, Jones R. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees. Eur Urol 2019; 77:223-250.
19.11.2019EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees
19.11.2019Eur Urol 2019; 77:223-250
Khoo Vincent, N'Dow James, Necchi Andrea, Neuzillet Yann, Oddens Jorg R, Oldenburg Jan, Osanto Susanne, J G Oyen Wim, Pacheco-Figueiredo Luís, Pappot Helle, Patel Manish I, Pieters Bradley R, Plass Karin, Remzi Mesut, Müller Christoph R, Müller Arndt-Christian, Kiltie Anne E, Krege Susanne, Ladoire Sylvain, Lara Pedro C, Leliveld Annemarie, Linares-Espinós Estefania, Løgager Vibeke, Lorch Anja, Loriot Yohann, Meijer Richard, Mir M Carmen, Moschini Marco, Mostafid Hugh, Retz Margitta, Richenberg Jonathan, Turkbey Baris, Lauridsen Susanne Vahr, Valdagni Riccardo, Der Heijden Antoine G Van, Van Poppel Hein, Vartolomei Mihai D, Veskimäe Erik, Vilaseca Antoni, Rivera Franklin A Vives, Wiegel Thomas, Wiklund Peter, Williams Andrew, Zigeuner Richard, Tombal Bertrand, Thalmann George N, Rink Michael, Roghmann Florian, Rosenberg Jonathan E, Rouprêt Morgan, Rouvière Olivier, Salembier Carl, Salminen Antti, Sargos Paul, Sengupta Shomik, Sherif Amir, Smeenk Robert J, Smits Anita, Stenzl Arnulf, Horwich Alan, Kamat Ashish M, Witjes J Alfred, Arends Tom, Bamias Aristotle, Birtle Alison, Black Peter C, Bochner Bernard H, Bolla Michel, Boormans Joost L, Bossi Alberto, Briganti Alberto, Brummelhuis Iris, Burger Max, Castellano Daniel, Cathomas Richard, Agarwal Neeraj, Xylinas Evanguelos, Babjuk Marek, Bellmunt Joaquim, Bruins H Maxim, de Reijke Theo M, De Santis Maria, Gillessen Sommer Silke, James Nicholas, MacLennan Steven, Palou Juan, Powles Tom, Ribal Maria J, Shariat Shahrokh F, Der Kwast Theo Van, Chiti Arturo, Choudhury Ananya, Gontero Paolo, Grubmüller Bernhard, Hafeez Shaista, Hansel Donna E, Hartmann Arndt, Hayne Dickon, Henry Ann M, Hernandez Virginia, Herr Harry, Herrmann Ken, Hoskin Peter, Huguet Jorge, Jereczek-Fossa Barbara A, Geavlete Bogdan, Gakis Georgios, Compérat Eva, Crabb Simon, Culine Stéphane, De Bari Berardino, De Blok Willem, J L De Visschere Pieter, Decaestecker Karel, Dimitropoulos Konstantinos, Dominguez-Escrig Jose L, Fanti Stefano, Fonteyne Valerie, Frydenberg Mark, Futterer Jurgen J, Jones Rob
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study
Loriot Y, Ouatas T, Holtkamp G, Baron B, Heeringa M, Baskin-Bey E, James N, Omlin A, Molife R, Van den Brande J, Jones R, Fizazi K, de Bono J. Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study. Invest New Drugs 2014; 32:995-1004.
27.04.2014Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study
27.04.2014Invest New Drugs 2014; 32:995-1004
Loriot Yohann, Ouatas Taoufik, Holtkamp Gertjan M, Baron Benoit, Heeringa Marten, Baskin-Bey Edwina, James Nicholas D, Omlin Aurelius, Molife Rhoda L, Van den Brande Jan, Jones Robert J, Fizazi Karim, de Bono Johann S